Trial Profile
Clinical Trials Insight: 700029915
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2009
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Simvastatin
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- Sponsors Pfizer; Wellpoint Health Networks
- 04 Dec 2008 Results were published in the December issue of Mayo Clinic Proceedings according to a Pfizer media release.
- 16 Jan 2008 New trial record.
- 15 Jan 2008 Results have been reported online.